High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy

Published:2019-12 Issue:12 Volume:37 Page:900-906
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Burgess Earle F.^ORCID,Livasy Chad,Trufan Sally,Hartman Aaron^ORCID,Guerreri Renato,Naso Caroline,Clark Peter E.,Grigg Claud^ORCID,Symanowski James,Raghavan Derek

Funder

Carolinas Bladder Cancer Fund

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference26 articles.

1. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis;Lancet,2003

2. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

3. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer;Raj;Cancer,2011

4. Shared and separate functions of polo-like kinases and aurora kinases in cancer;Lens;Nat Rev Cancer,2010

5. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53;Katayama;Nat Genet,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle‑invasive bladder cancer;Molecular and Clinical Oncology;2022-04-08

2. LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA;BMC Cancer;2021-10-26

3. Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer;Cancers;2021-04-01

4. Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker;Oncology Letters;2021-01-14

5. Urinary Biomarkers: Current Status and Future Opportunities;Comprehensive Diagnostic Approach to Bladder Cancer;2021